Nutrition 21, Inc., (NASDAQ: NXXI) the leading developer and marketer of chromium-based nutritional supplements, today announced the appointment of Dean DiMaria as the Company’s Vice President of Sales and Marketing. DiMaria will play a central role in the execution of the Company’s comprehensive marketing and distribution strategy for Chromax® chromium picolinate and Diachrome®.
DiMaria’s 22 years of consumer package experience include nine years at Pharmaton Natural Health Products and Boehringer Ingelheim Consumer Healthcare. At Pharmaton, after serving as Vice President of Sales of Natural Health Products, he served as General Manager and oversaw sales, marketing, market research and business development, as well as operations in general. DiMaria was instrumental to the development and execution of a marketing and sales strategy that established Pharmaton as the herbal category leader with $120 million in annual factory sales of its Ginsana, Ginkoba, Venastat and other brands.
“Dean’s proven track record, deep industry relationships, and expertise in marketing and sales will be an asset to Nutrition 21 as we enter into a phase of national distribution of our chromium products," said Paul Intlekofer, Chief Operating Officer of Nutrition 21. “We will be working closely with retailers to establish a destination on the shelf for Chromax similar to calcium and multi-vitamins.”
About Nutrition 21
Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax chromium picolinate, http://www.chromax.com/, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome®, which is available through diabetes educators or at http://www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at http://www.nutrition21.com.